Cyted Health Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 74

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $43.8M

  • Investors
  • 11

Cyted Health General Information

Description

Developer of non-endoscopic diagnostic technology designed for the early detection of esophageal diseases and cancer. The company's minimally invasive capsule sponge device, combined with advanced molecular diagnostics, enables safe and accessible esophageal cell collection in community settings, helping clinicians identify precursors like Barrett's Esophagus and move patients toward earlier treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ground floor Building 3
  • Old Swiss, 149 Cherry Hinton Road
  • Cambridge CB1 7BX
  • England, United Kingdom
+44 01480
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Decision/Risk Analysis
Corporate Office
  • Ground floor Building 3
  • Old Swiss, 149 Cherry Hinton Road
  • Cambridge CB1 7BX
  • England, United Kingdom
+44 01480

Cyted Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyted Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 29-Aug-2025 $43.8M Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
5. Later Stage VC 18-May-2023 Completed Generating Revenue
4. Grant 28-Apr-2023 Completed Generating Revenue
3. Grant 03-May-2022 Completed Generating Revenue
2. Early Stage VC 01-Feb-2020 $11.4M $11.4M Completed Generating Revenue
1. University Spin-Out 23-Jul-2018 Completed Startup
To view Cyted Health’s complete valuation and funding history, request access »

Cyted Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series B1
Series B
Series A 1
Series A 1
Ordinary 202,080 $0.001344 $4.21 $4.21 1x $4.21 1.63%
Series A 2,396,158 $0.001344 $4.21 $4.21 1x $4.21 19.37%
To view Cyted Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cyted Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-endoscopic diagnostic technology designed for the early detection of esophageal diseases and cancer. Th
Diagnostic Equipment
Cambridge, United Kingdom
74 As of 2026

Netanya, Israel
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyted Health Competitors (3)

One of Cyted Health’s 3 competitors is TytoCare, a Venture Capital-Backed company based in Netanya, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TytoCare Venture Capital-Backed Netanya, Israel
Gene By Gene Formerly VC-backed Houston, TX
Ava (Monitoring Equipment) Formerly VC-backed Zurich, Switzerland
You’re viewing 3 of 3 competitors. Get the full list »

Cyted Health Patents

Cyted Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202408601-D0 Training apparatus for oesophageal cell collection, and method for use thereof Active 14-Jun-2024
GB-2641895-A Training apparatus for oesophageal cell collection, and method for use thereof Active 14-Jun-2024
GB-2641895-B Training apparatus for oesophageal cell collection, and method for use thereof Active 14-Jun-2024
GB-202316758-D0 Diagnostic methods Inactive 01-Nov-2023
AU-2024336290-A1 A device for collecting cells with alternating wound retrieval thread Pending 07-Sep-2023 A61B10/02
To view Cyted Health’s complete patent history, request access »

Cyted Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyted Health Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent Life Sciences Venture Capital Minority
British Business Bank Lender/Debt Provider Minority
EQT Life Sciences Venture Capital Minority
MedTech Innovator Accelerator/Incubator
BGF (Financial Services) Growth/Expansion Minority
You’re viewing 5 of 11 investors. Get the full list »

Cyted Health Acquisitions (1)

Cyted Health’s most recent deal was a Merger/Acquisition with Pathognomics. The deal was made on 19-Oct-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pathognomics 19-Oct-2020 Merger/Acquisition Laboratory Services (Healthcare)
To view Cyted Health’s complete acquisitions history, request access »

Cyted Health FAQs

  • When was Cyted Health founded?

    Cyted Health was founded in 2018.

  • Where is Cyted Health headquartered?

    Cyted Health is headquartered in Cambridge, United Kingdom.

  • What is the size of Cyted Health?

    Cyted Health has 74 total employees.

  • What industry is Cyted Health in?

    Cyted Health’s primary industry is Diagnostic Equipment.

  • Is Cyted Health a private or public company?

    Cyted Health is a Private company.

  • What is the current valuation of Cyted Health?

    The current valuation of Cyted Health is .

  • What is Cyted Health’s current revenue?

    The current revenue for Cyted Health is .

  • How much funding has Cyted Health raised over time?

    Cyted Health has raised $67.9M.

  • Who are Cyted Health’s investors?

    Advent Life Sciences, British Business Bank, EQT Life Sciences, MedTech Innovator, and BGF (Financial Services) are 5 of 11 investors who have invested in Cyted Health.

  • Who are Cyted Health’s competitors?

    TytoCare, Gene By Gene, and Ava (Monitoring Equipment) are competitors of Cyted Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process